Siham Sabri

2.8k total citations
57 papers, 2.0k citations indexed

About

Siham Sabri is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Siham Sabri has authored 57 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 15 papers in Molecular Biology. Recurrent topics in Siham Sabri's work include Glioma Diagnosis and Treatment (15 papers), Cell Adhesion Molecules Research (9 papers) and Redox biology and oxidative stress (5 papers). Siham Sabri is often cited by papers focused on Glioma Diagnosis and Treatment (15 papers), Cell Adhesion Molecules Research (9 papers) and Redox biology and oxidative stress (5 papers). Siham Sabri collaborates with scholars based in Canada, France and United States. Siham Sabri's co-authors include Bassam Abdulkarim, David Lesniak, Ahmad Chaddad, Jean Deschênes, John Hanson, William Vainchenker, Paul Daniel, Bertrand J. Jean‐Claude, Julie Cuartero and Tamim Niazi and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Siham Sabri

51 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Siham Sabri Canada 26 603 569 525 397 375 57 2.0k
Martina Rudelius Germany 31 902 1.5× 1.1k 2.0× 366 0.7× 512 1.3× 306 0.8× 89 3.0k
Todd Hembrough United States 25 880 1.5× 942 1.7× 653 1.2× 232 0.6× 149 0.4× 71 2.3k
Tobias Dechow Germany 24 793 1.3× 692 1.2× 318 0.6× 246 0.6× 463 1.2× 73 2.0k
Christoph Schliemann Germany 30 1.2k 2.1× 1.0k 1.8× 335 0.6× 173 0.4× 637 1.7× 120 2.8k
Klaus Beiske Norway 35 1.2k 2.0× 938 1.6× 691 1.3× 589 1.5× 352 0.9× 119 4.1k
Takashi Imai Japan 26 505 0.8× 914 1.6× 345 0.7× 150 0.4× 631 1.7× 78 2.0k
Christopher D. Willey United States 28 777 1.3× 1.2k 2.2× 366 0.7× 329 0.8× 186 0.5× 118 2.5k
Olav Engebraaten Norway 29 925 1.5× 1.3k 2.3× 700 1.3× 289 0.7× 402 1.1× 87 2.7k
Bodour Salhia United States 26 580 1.0× 914 1.6× 483 0.9× 296 0.7× 111 0.3× 69 2.0k
Emiliano Cocco United States 32 1.6k 2.6× 1.1k 1.9× 532 1.0× 169 0.4× 305 0.8× 83 3.2k

Countries citing papers authored by Siham Sabri

Since Specialization
Citations

This map shows the geographic impact of Siham Sabri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siham Sabri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siham Sabri more than expected).

Fields of papers citing papers by Siham Sabri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Siham Sabri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siham Sabri. The network helps show where Siham Sabri may publish in the future.

Co-authorship network of co-authors of Siham Sabri

This figure shows the co-authorship network connecting the top 25 collaborators of Siham Sabri. A scholar is included among the top collaborators of Siham Sabri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Siham Sabri. Siham Sabri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sabri, Siham, et al.. (2025). Current insights on transglutaminase 2: Exploring its functions, mechanisms, and therapeutic potential in glioblastoma. Critical Reviews in Oncology/Hematology. 214. 104894–104894.
2.
Talib, Wamidh H., et al.. (2025). Melatonin and Vitamins: A Promising Combination to Augment Conventional Anticancer Therapies. Nutrients. 17(19). 3120–3120. 1 indexed citations
3.
Daniel, Paul, et al.. (2024). Synergistic Dual Targeting of Thioredoxin and Glutathione Systems Irrespective of p53 in Glioblastoma Stem Cells. Antioxidants. 13(10). 1201–1201. 5 indexed citations
4.
5.
Zorychta, Edith, et al.. (2023). Auranofin Induces Lethality Driven by Reactive Oxygen Species in High-Grade Serous Ovarian Cancer Cells. Cancers. 15(21). 5136–5136. 8 indexed citations
6.
Faye, Mame Daro, Jacob C. Easaw, Paula de Robles, et al.. (2023). Phase II trial of concurrent sunitinib, temozolomide, and radiotherapy with adjuvant temozolomide for newly diagnosed MGMT unmethylated glioblastoma. Neuro-Oncology Advances. 5(1). vdad106–vdad106. 5 indexed citations
7.
Sabri, Siham, et al.. (2023). STEM-08. OVERCOMING GLIOBLASTOMA STEM CELL RESISTANCE TO RADIATION THROUGH TARGETING THIOREDOXIN REDUCTASE 1. Neuro-Oncology. 25(Supplement_5). v34–v34. 1 indexed citations
8.
Sabri, Siham, et al.. (2022). Interactions between COVID-19 and Lung Cancer: Lessons Learned during the Pandemic. Cancers. 14(15). 3598–3598. 9 indexed citations
9.
Dai, Meiou, Ni Wang, Gang Yan, et al.. (2020). Differential Regulation of Cancer Progression by CDK4/6 Plays a Central Role in DNA Replication and Repair Pathways. Cancer Research. 81(5). 1332–1346. 32 indexed citations
10.
Abdulkarim, Bassam, Brian Meehan, Janusz Rak, et al.. (2019). Mechanisms and Antitumor Activity of a Binary EGFR/DNA–Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide. Clinical Cancer Research. 25(24). 7594–7608. 30 indexed citations
11.
Chaddad, Ahmad, Paul Daniel, Siham Sabri, Christian Desrosiers, & Bassam Abdulkarim. (2019). Integration of Radiomic and Multi-omic Analyses Predicts Survival of Newly Diagnosed IDH1 Wild-Type Glioblastoma. Cancers. 11(8). 1148–1148. 48 indexed citations
12.
Camirand, Anne, Bassam Abdulkarim, Atilla Ömeroğlu, et al.. (2019). PTHrP, A Biomarker for CNS Metastasis in Triple-Negative Breast Cancer and Selection for Adjuvant Chemotherapy in Node-Negative Disease. JNCI Cancer Spectrum. 4(1). pkz063–pkz063. 16 indexed citations
13.
Chabot, Catherine, Siham Sabri, Shuo Wang, et al.. (2019). An integrated stress response via PKR suppresses HER2+ cancers and improves trastuzumab therapy. Nature Communications. 10(1). 2139–2139. 48 indexed citations
14.
Daniel, Paul, Siham Sabri, Ahmad Chaddad, et al.. (2019). Temozolomide Induced Hypermutation in Glioma: Evolutionary Mechanisms and Therapeutic Opportunities. Frontiers in Oncology. 9. 41–41. 118 indexed citations
15.
Chatterjee, Avishek, Monica Serban, Bassam Abdulkarim, et al.. (2017). Performance of Knowledge-Based Radiation Therapy Planning for the Glioblastoma Disease Site. International Journal of Radiation Oncology*Biology*Physics. 99(4). 1021–1028. 39 indexed citations
16.
Jung, Karen, Siham Sabri, John Hanson, et al.. (2015). ElevatedARG1expression in primary monocytes-derived macrophages as a predictor of radiation-induced acute skin toxicities in early breast cancer patients. Cancer Biology & Therapy. 16(9). 1281–1288. 10 indexed citations
17.
Abdulkarim, Bassam, Yaoxian Xu, Marie‐Christine Guiot, et al.. (2012). O(6)-Methylguanine-DNA Methyltransferase Is a Novel Negative Effector of Invasion in Glioblastoma Multiforme. Molecular Cancer Therapeutics. 11(11). 2440–2450. 20 indexed citations
18.
Lesniak, David, Yaoxian Xu, Jean Deschênes, et al.. (2009). β1-Integrin Circumvents the Antiproliferative Effects of Trastuzumab in Human Epidermal Growth Factor Receptor-2–Positive Breast Cancer. Cancer Research. 69(22). 8620–8628. 71 indexed citations
19.
Abdulkarim, Bassam, Siham Sabri, Éric Deutsch, et al.. (2002). Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers. Oncogene. 21(15). 2334–2346. 104 indexed citations
20.
Abdulkarim, Bassam, Siham Sabri, Éric Deutsch, et al.. (2000). Radiation-induced expression of functional Fas ligand in EBV-positive human nasopharyngeal carcinoma cells. International Journal of Cancer. 86(2). 229–237. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martina Rudelius Breakdown of academic impact, for papers by Todd Hembrough Breakdown of academic impact, for papers by Tobias Dechow Breakdown of academic impact, for papers by Christoph Schliemann Breakdown of academic impact, for papers by Klaus Beiske Breakdown of academic impact, for papers by Takashi Imai Breakdown of academic impact, for papers by Christopher D. Willey Breakdown of academic impact, for papers by Olav Engebraaten Breakdown of academic impact, for papers by Bodour Salhia Breakdown of academic impact, for papers by Emiliano Cocco
Rankless by CCL
2026